INTRODUCTION {#sec1-1}
============

Polyomavirus BK virus, a small DNA virus, belongs to the polyomaviridae family. This family includes at least two additional viruses: the JC virus (JCV) and the simian virus SV40.\[[@ref1]\] Agnoprotein, a subunit of polyomavirus genome, not only contains important regulatory elements but also its interaction with viral capsid proteins results in the formation of promyelocytic leukemia bodies.\[[@ref2]--[@ref4]\] It has been reported that up to 90% of normal population changes to seropositive status between 5 and 10 years of age.\[[@ref5]--[@ref8]\] Immunocompromised situations such as solid or bone marrow organ transplantation and receiving immunosuppressant medications may activate latent BK virus infection.\[[@ref4][@ref9]--[@ref11]\] While renal dysfunction is more prevalent in kidney transplant recipients, hemorrhagic cystitis is more possible to occur in bone marrow transplanted patients.\[[@ref1]\] Polyomavirus tumor antigen (T Ag) sequences, especially SV40 specific, were detected in non-Hodgkin lymphoma.\[[@ref12]\] Furthermore, it has been assumed that the rate of multiple virus isolation is significantly greater in children with acute lymphoblastic leukemia (ALL) than normal population.\[[@ref13]\] It has been still debated whether BKV infection may increase the risk of lymphoblastic leukemia or not. Considering the scarce data about the incidence of BKV infection in children with ALL, we conducted this study on the newly diagnosed leukemic children to investigate the urinary excretion of BKV and its possible relation with triggering the disease.

METHODS {#sec1-2}
=======

This cross-sectional case--control study was carried out on 62 participants, aged 1--18 years, in Saint Al-Zahra Hospital, Isfahan, Iran. The participants included 32 cases of children newly diagnosed with ALL and 32 normal children referred to the hospitals for routine health evaluation as the control group.

Inclusion criteria for the case group:

Age less than 18 years at the time of diagnosis.Newly diagnosed as ALL (less than 3 months).No evidence of urinary tract infection at the time of urine sampling.

Inclusion criteria for the control group:

No evidence of chronic diseases.No past history of recent treatment with steroids (oral or inhaler).No history of recent urinary tract infection.No gross anatomical and physical abnormality or syndromic phenotypes.No sign of failure to thrive and malnutrition.

The first fasting urine sample was collected to increase the chance of finding urinary epithelial cells. The samples were carried on ice to the laboratory immediately. Urine specimens (15 ml) were centrifuged at 3500 rpm for 15 min. The sediments were frozen at --70°C.

Genomic DNA was extracted from the thawed samples by phenol/chloroform method.\[[@ref1]\] The extracted DNA in TE buffer was stored at --20°C until analysis by polymerase chain reaction (PCR) method. The quality of the DNA was evaluated by PCR using beta-globin specific primers.\[[@ref14]\] A PCR method was used to detect the BK virus in specimens. PCR amplification was performed using specific primers of PEP- 1 (5′-AGTCTTTAGGGTCTTCTACC-3′) and PEP-2 (5′-GGTGCCAACCTATGGAACAG-3′).\[[@ref15]\] Each PCR reaction was carried out in a total volume of 50 μl containing 1× PCR buffer, 1 mM MgCl~2~, 2.5 pmol of each primer, 0.2 mmol dNTP, 1.5 U Taq DNA polymerase (Sinagene, Tehran, Iran), 10 μl template DNA, and distilled water, to a total volume of 50 μl. The PCR was performed in thermal cycler Master (Eppendorf, Germany). The amplification conditions were as follows: 94°C for 5 min; followed by 40 cycles at 94°C for 1 min, 55°C for 1 min, 72°C for 2 min, and a final extension at 72°C for 5 min. Purified BKV genome as positive control and distilled water as negative control were included in all runs. PCR products were analyzed on agarose gel electrophoresis followed by ethidium bromide staining.

RESULTS {#sec1-3}
=======

Thirty-five out of 62 participants (54.8%) were males and the remaining were females. The mean age of diagnosis of ALL in the case group was 6.25 ± 3.58 years. However, the mean ages of urine sampling for BKV in case and control groups were not significantly different (6.97 ± 4.11 years vs. 7.13 ± 3.14 years, respectively; *P* \> 0.05). The mean duration of follow-up was 9.6 ± 6.09 months. Central nervous system (CNS) disease was reported in 29% of the patients. CNS relapse was reported in 12.7% of the patients. There was a significant correlation between the frequency of radiotherapy with CNS relapses and death (*P* \< 0.001). The most prevalent abnormalities in complete blood count (CBC) results were anemia and thrombocytopenia. In addition, low hemoglobin level significantly correlated with the overall mortality (*P* \< 0.05). However, leukocytosis was not a common finding in our patients \[[Table 1](#T1){ref-type="table"}\]. Conventional PCR on the first morning urine samples revealed positive results in three children with ALL (9.7%). No positive PCR result was achieved in the control group. However, Fisher\'s exact test did not show any significant difference between the two groups (*P* \> 0.05) \[[Table 2](#T2){ref-type="table"}\]. In addition, there was no significant correlation between BKV positivity and frequency of relapses \[[Table 3](#T3){ref-type="table"}\]. Furthermore, the mean time of diagnosis ALL was not different between BKV positive and negative groups (*P* \> 0.05). There was no correlation between urine BKV positivity and CBC parameter abnormalities (data not shown). Eight patients out of 32 (25.8%) died before the survey was completed.
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DISCUSSION {#sec1-4}
==========

According to our knowledge, this is the first study evaluating urinary BKC excretion in children newly diagnosed with ALL. We demonstrated the presence of BKV in urine of this group of patients before the prescribed medications changed the patients' immunostatus.

It has been demonstrated that cells infected with BKV undergo two different processes: cell lysis and cell transformation or abortive infection.\[[@ref16]--[@ref18]\] Urogenital and mononuclear cells have been shown as the sites for dissemination and perseverance of BKV.\[[@ref19]--[@ref21]\] The *in vitro* and *in vivo* behaviors of BKV make the virus notorious as a tumor virus. Detecting BKV in peripheral blood cells has led to the hypothesis of involvement of BKV in lymphoma.\[[@ref19][@ref20]\] In animal models, BKV inoculation resulted in evolving different types of tumors.\[[@ref18]--[@ref22]\] Immunocompromised conditions resulting from diseases and/or numerous immunosuppressor medications reactivate BKV infection.\[[@ref23]\] JC virus, another member of the polyomaviridae family, has been associated with human cancers. However, a large percentage of the normal population is seropositive for JCV up to adolescence.\[[@ref24]\] Transcription and DNA replication of JCV is regulated by T Ag protein. The presence of JCV and its regulatory protein, T Ag, in tumoral cells has led to hypothesize that JCV infection and T Ag might cause abnormal cell growth and solid tumor formation such as gastrointestinal cancers, brain tumors, and lung cancers.\[[@ref24]--[@ref31]\]

ALL is the most common malignancy in children with a peak incidence in 2--5 years of age. The mean age of our patients was in the upper limit of the mentioned range. Relapse of ALL is not uncommon in children. Bone marrow and CNS are the most common sites of relapses.\[[@ref32]\] Our patients frequently experienced relapses. There was a correlation between frequency of relapses, CNS relapses, and overall mortality. All of our patients had CNS relapses. Although isolated CNS relapses have been shown with better survival, bone marrow relapse makes the outcome poorer.\[[@ref33]\] The mortality of our patients correlated with CNS relapses and the frequency of radiotherapy courses. Most of our patients who died had simultaneous bone marrow and CNS relapses.

Numerous studies have shown the role of infections in developing ALL.\[[@ref34][@ref35]\] Regarding the presence of BKV-DNA sequences in normal human tissues and the expression of T Ag (BKV viral protein) in neoplastic tissues, BKV has been assumed to have the potential ability to act as a carcinogen.\[[@ref36]\] In addition, Jiang *et al*. revealed the interaction between promyelocytic leukemia nuclear bodies (PML-NBs) and BKV. According to their study, BKV infection is accompanied with reduction in PML-NBs number and enlargement in size. Therefore, the reorganization of PML-NBs used by BKV inactivates antiviral function of PML-NBs.\[[@ref37]\] Mc Nally and colleagues reported a significant cross-clustering between leukemia and CNS tumors. Furthermore, they proposed a consistency between infectious etiology for childhood leukemia and CNS tumors.\[[@ref38]\] However, Smith *et al*. did not demonstrate polyomavirus sequences in samples derived from leukemic cells with amplifiable DNA.\[[@ref39]\] There is not any consensus on the laboratory strategies to screen BKV infection in susceptible population. Presence of Decoy cells in the urine of patients has been suggested as a sensitive tool to demonstrate overt BKV nephropathy.\[[@ref1]\] Conversely, PCR has been assumed with higher sensitivity for detecting asymptomatic viruria and distinguishing BK viruria from JC viruria.\[[@ref40]\] Tracking BK virus infection is possible by serial measurement of BK virus DNA in urine and blood using quantitative PCR method.\[[@ref41]\] Urinary excretion of JC virus and BKV has been also reported in 19% and 7% of healthy asymptomatic population, respectively.\[[@ref42]\] Regarding the high rate of BKV seropositivity in population, we used conventional PCR method to detect asymptomatic viruria. Choosing newly diagnosed patients helped the authors to diminish the possibility of acquired drug-induced immunodeficiency. Irrespective of showing urinary BKV excretion, no additive sign or symptom demonstrating BKV nephropathy was determined. Confirming BKV nephropathy (disease) needs serial evaluation of BKV-DNA in blood and urine samples predominantly by real-time PCR. In our study, 3 out of 31 patients with newly diagnosed ALL had BK viruria. We did not show BK viruria in the control group. Nonetheless, there was not any significant difference between BK viruria in ALL children and the control group. The result did not support the possible hypothesis that BKV activation may have a role in inducing ALL. However, large sample size of newly diagnosed ALL is recommended to evaluate the possible role of BKV in this group of patients. Furthermore, there was not any correlation between relapses and viruria. Long-term follow-up is needed to assess whether evolving BK viruria increases the chance of recurrent relapses. The rate of CNS relapse in our study was a bit higher compared to those reported by Pullen *et al*. and Pui *et al*. in their studies (12.7% vs. 7.7% and 5.9% in poor outcome group).\[[@ref43][@ref44]\] The shortage of newly diagnosed children with ALL because of low incidence of the disease was the limitation of our study.

CONCLUSION {#sec1-5}
==========

BK viruria is not uncommon in children with newly diagnosed ALL. Although the incidence of BK viruria in ALL children is not significantly higher than normal population, proving the role of BKV in increasing the relapse rate of ALL needs longer cohort studies.
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